Construction group Leighton Holdings has won a $US74 million ($A72.47 million) contract to build the first proton cancer therapy centre in Saudi Arabia.
Proton therapy is a form of radiation used to treat cancer.
Leighton’s Middle Eastern joint venture Habtoor Leighton Group won the contract to build the centre at King Fahad Medical City in Riyadh in a 50/50 joint venture with Al Latifia Trading and Contracting.
It is the second healthcare contract Habtoor Leighton has won in Saudi Arabia in a month.
In September, it won a a $US316 million ($A309.46 million) deal – also with Al Latifia Trading and Contracting – to build new medical centres.
Habtoor Leighton’s new managing director Jose Antonio Lopez-Monis, who was appointed in between the two deals, said the delivery of the proton therapy centre would provide Saudi Arabia, and neighbouring Gulf states, with access to the best cancer treatment technology in the world.
The Middle Eastern group has been posting losses, with Leighton writing down its carrying value from $379 million to $347 in August.
Leighton shares were one cent down at $17.24 at 1125 AEDT.
